Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions

International Journal of Gynecological Pathology

Volumn 25, Issue 1, 2006, Pages 30-37

  Brustmann, Hermann ^a  

^a Thermenklinikum ^*  (Austria)

Author keywords

CD1a; Dendratic cells; Galectin 3; Squamous cell carcinoma; Vulva

Indexed keywords

GALECTIN 3; MONOCLONAL ANTIBODY; T6 ANTIGEN; CD1 ANTIGEN; KERATIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CONDYLOMA; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; VULVA CANCER; CARCINOMA IN SITU; CONDYLOMA ACUMINATUM; KERATINOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; VULVA; VULVA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; DENDRITIC CELLS; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KERATINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL; VULVA; VULVAR NEOPLASMS;

EID: 33644820270     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000179613.40215.c0     Document Type: Article

References (34)

1. Creasman WT, Phillips H, Menck HR. The national cancer data base report on early stage invasive vulvar carcinoma. Cancer 1997;80:505-13.
2. Lerma E, Matias-Guiu X, Lee SJ, et al. Squamous cell carcinoma of the vulva: Study of ploidy, HPV, p53, and pRb. Int J Gynecol Pathol 1999;18:191-7.
3. Clement PB, Young RH. Malignant tumors of the vulva. In: Bordin GM, ed. Atlas of Gynecologic Surgical Pathology. Philadelphia, PA: Saunders, 2000:22-7.
4. Prat J. Pathology of vulvar intraepithelial lesions and early invasive carcinoma. Hum Pathol 1991;22:877-83.
5. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995;26:147-54.
6. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991;10:107-25.
7. Barondes SH, Cooper DNW, Gitt MA, et al. Galectins: structure and function of a large family of animal lectins. J Biol Chem 1994;269:20807-10.
8. Linstedt R, Apodaca G, Barondes SH, et al. Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells: evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J Biol Chem 1993;268:11750-7.
9. Ohannesian DW, Lotan D, Thomas P, et al. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human carcinoma cells. Cancer Res 1995;55:2191-9.
10. Bresalier RS, Byrd JC, Wang L, et al. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res 1996;56:4534-7.
11. Moutsatsos IK, Wade M, Schindler M, et al. Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci USA 1987;84:6452-6.
12. Frigeri LG, Zuberi RI, Liu FT, et al. A beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RT) and activates mast cells. Biochemistry 1993;32:7644-9.
13. Fukumori T, Takenaka Y, Yoshii T, et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 2003;63:8302-11.
14. Inohara H, Raz A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 1995;55:3267-71.
15. Raz A, Zhu D, Hogan V, et al. Evidence for the role of 34 kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 1990;46:871-7.
16. Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000;156:899-909.
17. Xu XC, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors - potential diagnostic implications. Am J Pathol 1995;147:815-22.
18. Delorge S, Saussez S, Pelc P, et al. Correlation of galectin-3/galectin- 3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 2000;122:834-41.
19. Honjo Y, Inohara H, Akahani S, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000;6:4635-40.
20. Schwarz G Jr, Remmelink M, Decaestecker C, et al. Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3-binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors. Am J Clin Pathol 1999;111:623-31.
21. Honjo Y, Nangia-Makker P, Inohara H, et al. Down-regulation of galectin-3 suppresses tumorigenicity of human breats carcinoma cells. Clin Cancer Res 2001;7:661-8.
22. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
23. Eisenthal A, Polyvkin N, Bramante-Schreiber L, et al. Expression of dendritic cells in ovarian tumors correlated with clinical outcome in patients with ovarian cancer. Hum Pathol 2001;32:803-7.
24. Takagi S, Shin-ichi M, Ichikawa E, et al. Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma. Hum Pathol 2004;35:881-6.
25. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.
26. Gong HC, Honjo Y, Nangia-Makker P, et al. The NH2 terminus of galectin-3 governs cellular compartimentalization and functions in cancer cells. Cancer Res 1999;59:6239-45.
27. Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002;277:6852-7.
28. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996;93:6737-42.
29. Plzak J, Smetana K Jr, Hrdlickova E, et al. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol 2001;19:59-64.
30. Shekar MP, Nangia-Makker P, Tait L, et al. Alterations in galectin-3 expression and distribution correlate with breats cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions. Am J Pathol 2004;165:1931-41.
31. Giannini SL, Hubert P, Doyen J, et al. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer 2002;97:654-9.
32. Kobayashi A, Greenblatt RM, Anastos K, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 2004;64:6766-74.
33. Davidson EJ, Boswell CM, Sehr P, et al. Immunological and clinical responses in women with vulvar intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res 2003;63:6032-41.
34. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999;10:1417-25.